For PatientsContact Us

Investor Relations

PharmD Live® is on a mission to redefine how chronic care and medication management are delivered in value-based care. Our scalable model blends AI-powered insights, clinical pharmacist expertise, and multidisciplinary care teams — delivering measurable cost savings and improved patient outcomes across the healthcare ecosystem.

Read more about our company, check our latest announcements, or reach out with investor inquiries.
Investor Relations

Invest in the future of smarter, safer healthcare.

PharmD Live® is redefining chronic care and medication management in value-based care. Our scalable model blends intelligent insights, clinical pharmacist expertise, and multidisciplinary care teams to deliver measurable cost savings and improved patient outcomes.

$8.6M Annualized cost savings across live contracts Proven ROI
91 Exceptional Net Promoter Score among patients and providers Strong experience
Recurring Revenue from multi-year contracts with ACOs, hospitals and provider groups Scalable model
Why PharmD Live®

A focused investment case built around value-based care.

PharmD Live® combines clinical depth, intelligent risk identification, and a scalable care model to address costly failures in chronic care and medication management.

01

Scalable model with proven ROI

Company-reported cost savings, strong experience scores, and recurring multi-year contracts demonstrate a model designed to create durable value for healthcare partners.

02

Strong market opportunity

Chronic disease burden, continued value-based care adoption, and growing federal support for preventive and remote care expand the need for scalable clinical services.

03

Technology plus clinical leadership

Proprietary risk-stratification technology is paired with clinical pharmacist expertise and multidisciplinary care teams focused on chronic disease and medication safety.

Market Opportunity

Aligned with healthcare’s shift toward prevention, coordination and value.

PharmD Live® is positioned where major healthcare priorities converge: managing chronic disease, improving medication outcomes, and extending coordinated care beyond the exam room.

133M

Americans live with chronic conditions, creating sustained demand for coordinated and scalable care management.

75%

Projected value-based care penetration among Medicare lives by 2030.

Increasing federal incentives support preventive and remote care programs across the healthcare ecosystem.

Technology + Team

The convergence of intelligent insight and clinical expertise.

The PharmD Live® model brings together technology and clinical leadership rather than treating them as separate capabilities.

Technology

Risk-stratification intelligence

AI-powered insights and proprietary risk-stratification capabilities help surface patient risk and opportunities for timely intervention.

  • Data-informed identification of patient risk
  • Scalable support across patient populations
  • Technology designed to strengthen clinical action
Clinical Leadership

Pharmacist-led, multidisciplinary care

Clinical pharmacists and multidisciplinary care teams bring deep expertise in chronic disease and medication safety to each partnership.

  • Clinical pharmacist expertise
  • Multidisciplinary care-team collaboration
  • Medication-safety and chronic-care focus
Join Our Growth Story

Investment and strategic partnership pathways.

PharmD Live® welcomes mission-aligned investors and strategic partners who share our vision for safer medication use, stronger chronic care, and better value-based outcomes.

Seed

Early growth capital

Support continued expansion of clinical operations, market reach, and revenue-producing healthcare partnerships.

Series A

Scale the platform

Accelerate technology, care-delivery capacity, and enterprise growth across healthcare markets.

Strategic Partnership

Create shared value

Explore strategic alignment that extends distribution, capabilities, and clinical impact.

Investor Relations

Ready to learn more?

Connect with the PharmD Live® executive team to discuss investment interest, strategic alignment, and the company’s next phase of growth.

This page is provided for general informational purposes only and does not constitute an offer to sell or a solicitation to purchase securities. Performance indicators shown are company-reported.